Charles C. Dunham, IV
Epstein Becker Green
Articles
Genetic Testing Company Agrees to Pay $1.99 Million to Resolve Allegations that it Violated the False Claims Act By Billing for Tests Not Covered Under Local Coverage Determinations
USA - February 14 2019 GenomeDx Biosciences Corp., which markets a genomic test (Decipher®) intended to assess the aggressiveness of prostate cancer, has agreed to pay $1…
The SUPPORT for Patients and Communities Act: Part 1: New Federal Anti-Kickback Law - Eliminating Kickbacks in Recovery Act of 2018
USA - December 10 2018 President Trump recently signed sweeping bipartisan legislation to combat the opioid epidemic. TheSubstance Use-Disorder Prevention that Promotes…
Sales and Marketing Compliance: New Federal Anti-Kickback Law May Alter How Clinical Laboratories Compensate Sales Personnel
USA - November 20 2018 Clinical laboratories need to review how they compensate sales personnel following the passage of the Eliminating Kickbacks in Recovery Act of 2018…
Hospitals Need to Be Aware of CMS Changes to PAMA
USA - November 20 2018 The Centers for Medicare & Medicaid Services (CMS) issued a final rule on November 1, 2018 that updates physician fee schedule (PFS) payments for…
The SUPPORT for Patients and Communities Act: Expanding Medicare Coverage of Telehealth Services to Combat the Opioid Crisis
USA - November 5 2018 The SUPPORT for Patients and Communities Act (“the Act” or “the SUPPORT Act”), signed into law by President Trump on October 24, 2018, is intended to…
